On october 2, 2017 Celgene Corporation (NASDAQ: CELG) reported that it will host a conference call and live audio webcast on Thursday, October 26, 2017 at 9 a.m. ET to discuss third quarter 2017 financial and operational results (Press release, Celgene, OCT 2, 2017, View Source [SID1234520900]). The webcast can be accessed from the Investor Relations page at www.celgene.com.
Celgene will also host a webcast of an investor event at the MSParis2017-7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) – American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Meeting on Saturday, October 28 at 6:00 p.m. CEST (12:00 p.m. ET). Members of Celgene’s management team and clinical investigators will discuss the data presentations at the ECTRIMS Meeting. The event will be webcast live and will be available in the Investor Relations section of the Company’s web site at www.celgene.com.